Ad is loading...
GSROX
Price
$15.22
Change
+$0.26 (+1.74%)
Updated
Nov 22 closing price
VISGX
Price
$83.69
Change
+$1.46 (+1.78%)
Updated
Nov 22 closing price
Ad is loading...

GSROX vs VISGX

Header iconGSROX vs VISGX Comparison
Open Charts GSROX vs VISGXBanner chart's image
Goldman Sachs Small Cap Gr Insghts R
Price$15.22
Change+$0.26 (+1.74%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Growth Index I
Price$83.69
Change+$1.46 (+1.78%)
VolumeN/A
CapitalizationN/A
GSROX vs VISGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSROX vs. VISGX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSROX is a StrongBuy and VISGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 35.8B vs. GSROX (140M). VISGX pays higher dividends than GSROX: VISGX (0.55) vs GSROX (0.00). GSROX was incepted earlier than VISGX: GSROX (17 years) vs VISGX (27 years). GSROX is a more actively managed with annual turnover of: 153.00 vs. VISGX (19.00). GSROX has a lower initial minimum investment than VISGX: GSROX (0) vs VISGX (3000). GSROX annual gain was more profitable for investors over the last year : 38.56 vs. VISGX (35.67). VISGX return over 5 years is better than : 53.45 vs. GSROX (-57.16).
GSROXVISGXGSROX / VISGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years27 years-
Gain YTD25.19221.206119%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets140M35.8B0%
Annual Yield % from dividends0.000.55-
Returns for 1 year38.5635.67108%
Returns for 3 years-67.751.53-4,433%
Returns for 5 years-57.1653.45-107%
Returns for 10 years-53.04136.51-39%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZG79.264.26
+5.68%
Zillow Group
WOOF4.170.20
+5.04%
Petco Health and Wellness Company
PTGX41.651.00
+2.46%
Protagonist Therapeutics
MVO9.140.06
+0.66%
MV Oil Trust
HSDT0.43-0.02
-4.87%
Helius Medical Technologies